Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 4, 2013, Pages 459-465

  Zhang, Li ^a   Cheng, Zhenshun ^a   Liu, Weimin ^a   Wu, Kaisong ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Airway inflammation.; Chronic obstructive pulmonary disease (COPD); IL 10; IL 22; Interleukin (IL) 17

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOKING; SPUTUM ANALYSIS; SPUTUM LEVEL;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKINS; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM;

EID: 84880720706     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.770456     Document Type: Article

References (36)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370(9589):765-773.
2. Di Stefano A, Caramori G, Gnemmi I, Contoli M, Vicari C, Capelli A, Magno F, D'Anna SE, Zanini A, Brun P, Casolari P, Chung KF, Barnes PJ, Papi A, Adcock I, Balbi B. Thhelper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 2009; 157(2):316-324.
3. Eustace A, Smyth LJ, Mitchell L, Williamson K, Plumb J, Singh D. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest 2011; 139(5):1089-100.
4. Chang Y, Nadigel J, Boulais N, Bourbeau J, Maltais F, Eidelman DH, Hamid Q. CD8 positive Thcells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res 2011; 12: 43.
5. Vargas-Rojas MI, Ramírez-Venegas A, Limón-Camacho L, Ochoa L, Hernández-Zenteno R, Sansores RH. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011; 105(11):1648-1654.
6. Shen N, Wang J, Zhao M, Pei F, He B. Anti-interleukin-17 antibodies attenuate airway infl ammation in tobacco-smoke-exposed mice. Inhal Toxicol 2011; 23(4):212-218.
7. Barczyk A, Pierzchala W, Sozañska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003; 97(6):726-733.
8. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, McCormick M, Woods J, May R, Sleeman MA, Anderson IK, Brightling CE. Expression of the Thhelper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010; 138(5):1140-1147.
9. Paats MS, Bergen IM, Hoogsteden HC, van der Eerden MM, Hendriks RW. Systemic CD4+ and CD8+ Thcell cytokine profiles correlate with GOLD stage in stable COPD. Eur Respir J 2012; 40(2):330-337.
10. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008; 180(9):5771-5777.
11. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in infl ammation and disease. Annu Rev Immunol 2011; 29:71-109.
12. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Antiinfl ammatory and pro-infl ammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 2009; 9(4):447-453.
13. Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, Satoh K, Okamura K. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 1999; 14(2)309-314.
14. Moermans C, Heinen V, Nguyen M, Henket M, Sele J, Manise M, Corhay JL, Louis R. Local and systemic cellular infl ammation and cytokine release in chronic obstructive pulmonary disease. Cytokine 2011; 56(2):298-304.
15. Pelegrino NR, Tanni SE, Amaral RA, Angeleli AY, Correa C, Godoy I. Effects of active smoking on airway and systemic infl ammation profiles in patients with Chronic Obstructive Pulmonary Disease. Am J Med Sci 2012; Aug 7.
16. Hackett TL, Holloway R, Holgate ST, Warner JA. Dynamics of pro-infl ammatory and anti-infl ammatory cytokine release during acute infl ammation in chronic obstructive pulmonary disease: an ex vivo study. Respir Res 2008; 9:47.
17. Barceló B, Pons J, Fuster A, Sauleda J, Noguera A, Ferrer JM, Agustí AG. Intracellular cytokine profile of Thlymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2006; 145(3):474-479.
18. Cosio BG, Iglesias A, Rios A, Noguera A, Sala E, Ito K, Barnes PJ, Agusti A. Low-dose theophylline enhances the anti-infl ammatory effects of steroids during exacerbations of COPD. Thorax 2009; 64(5):424-429.
19. Murdoch JR, Lloyd CM. Resolution of allergic airway infl ammation and airway hyperreactivity is mediated byIL-17-producing {gamma}{delta}T cells. Am J Respir Crit Care Med 2010; 182(4):464-476.
20. Lee KA, Kang MH, Lee YS, Kim YJ, Kim DH, Ko HJ, Kang CY. A distinct subset of natural killer Thcells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. Cell Immunol 2008; 251(1):50-55.
21. Kondo T, Takata H, Matsuki F, Takiguchi M. Cutting edge: Phenotypic characterization and differentiation of human CD8+ Tcells producing IL-17. J Immunol 2009; 182(4):1794-1798.
22. Cazzola M, Matera MG. IL-17 in chronic obstructive pulmonary disease. Expert Rev Respir Med 2012; 6(2): 135-8.
23. Vanaudenaerde BM, Verleden SE, Vos R, De Vleeschauwer SI, Willems-Widyastuti A, Geenens R, Van Raemdonck DE, Dupont LJ, Verbeken EK, Meyts I. Innate and adaptive interleukin-17-producing lymphocytes in chronic infl ammatory lung disorders. Am J Respir Crit Care Med 2011; 183(8):977-986.
24. Hong SC, Lee SH. Role of th17 cell and autoimmunity in chronic obstructive pulmonary disease. Immune Netw 2010; 10(4):109-114.
25. Fujisawa T, Velichko S, Thai P, Hung LY, Huang F, Wu R. Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J Immunol 2009;183(10):6236-6243.
26. Zhang X, Zheng H, Zhang H, Ma W, Wang F, Liu C, He S. Increased interleukin (IL)-8 and decreased IL-17 production in chronic obstructive pulmonary disease (COPD) provoked by cigarette smoke. Cytokine 2011; 56(3):717-725.
27. Rahman MS, Yang J, Shan LY, et al. IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism. Clin Immunol 2005; 115:268-276.
28. Vanaudenaerde BM, Wuyts WA, Dupont LJ, Van Raemdonck DE, Demedts MM, Verleden GM. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro:a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003; 22:1280-1283.
29. Roussel L, Houle F, Chan C, Yao Y, Bérubé J, Olivenstein R, et al. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of infl ammation. J Immunol 2010; 184(8):4531-4537.
30. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175(3): 250-255.
31. Zhu J, Cao Y, Li K, Wang Z, Zuo P, Xiong W, Xu Y, Xiong S. Increased expression of aryl hydrocarbon receptor and interleukin 22 in patients with allergic asthma. Asian Pac J Allergy Immunol 2011; 29(3): 266-272.
32. Nakagome K, Imamura M, Kawahata K, Harada H, Okunishi K, Matsumoto T, Sasaki O, Tanaka R, Kano MR, Chang H, Hanawa H, Miyazaki J, Yamamoto K, Dohi M. High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway infl ammation via an IL-10-associated mechanism. J Immunol 2011; 187(10): 5077-89.
33. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human Thcell subset involved in epidermal immunity and remodeling. J Clin Invest 2009; 119(12): 3573-85.
34. Rico de Souza A, Zago M, Pollock SJ, Sime PJ, Phipps RP, Baglole CJ. Genetic ablation of the aryl hydrocarbon receptor causes cigarette smoke-induced mitochondrial dysfunction and apoptosis. J Biol Chem 2011; 286(50): 43214-28.
35. Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, Dayer JM, et al. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human Thhelper cells. Eur J Immunol 2010; 40(9): 2450-9.
36. Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway infl ammation. Curr Mol Med 2008; 8(5): 437-45.